CREBBP and B-cell non-Hodgkin lymphoma: The majority of the mutations in these genes were truncating variants that include the disruptive SV in CREBBP. This is in agreement with previous findings [14] that the loss-of-function of these genes is pathogenically involved in B-cell lymphoma.